Virazole Cream Approved In Russian Federation For Treatment Of Herpes
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Virazole Cream Approved In Russian Federation For Treatment Of Herpes

NEW YORK, NY -- July 16, 1998 – The Health Ministry of the Russian Federation has approved ICN Pharmaceuticals. Inc.’s 7.5% Virazole(R) (ribavirin) Cream for the treatment of herpes zoster and herpes genitalis.

Virazole Cream is produced by ICN Mexico. It is approved and marketed in Mexico under the name Virazide.

Ribavirin is a synthetic nucleoside analog with broad-spectrum antiviral activity. ICN, which discovered ribavirin, currently markets the drug as Virazole in a variety of dosage forms for at least one of 10 indications in 44 countries. Virazole currently is sold in the U.S. and the European Union (EU) only for aerosol use for the treatment of hospitalised infants and young children with lower respiratory infection due to respiratory syncytial virus (RSV). Virazole is also marketed in Yugoslavia as an injectable used to treat hemorrhagic fever.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities